Literature DB >> 32182608

Long Non-Coding RNA CRNDE Regulates Angiogenesis in Hepatoblastoma by Targeting the MiR-203/VEGFA Axis.

Li-Jian Chen1, Miao-Xian Yuan1, Chun-Yi Ji1, Yan-Bing Zhang1, Yu-Ming Peng1, Tian Zhang1, Hong-Qiang Gao1, Xin-Yi Sheng1, Zhao-Yang Liu1, Wei-Xin Xie1, Qiang Yin2.   

Abstract

OBJECTIVE: MiR-203 has been shown to participate in multiple malignancies, but the role of miR-203 in hepatoblastoma (HB) remains unclear. The aim of our study was to investigate the effects of miR-203 in HB.
METHODS: A total of 15 pairs of HB tissues and para-tumour normal tissues were collected for the experiments. RT-qPCR and Western blotting were performed to detect the expression of CRNDE, miR-203, and VEGFA at the mRNA and/or protein levels, respectively. A dual luciferase assay verified the target relationship between miR-203 and the 3'UTR of VEGFA as well as miR-203 and CRNDE. In addition, MTT, wound healing, and tube formation assays were performed to assess the effects of miR-203, VEGFA, and CRNDE on cell proliferation, migration, and angiogenesis, respectively.
RESULTS: Our data revealed that miR-203 expression was decreased in HB tissues, while long non-coding RNA (lncRNA) CRNDE expression was increased. The dysregulation of miR-203 and CRNDE was closely related to tumour size and stage. Moreover, overexpression of miR-203 inhibited angiogenesis. A dual luciferase assay verified that VEGFA is a direct target of miR-203 and that CRNDE binds to miR-203. Furthermore, our results showed that miR-203 suppressed cell viability, migration, and angiogenesis by regulating VEGFA expression. Additionally, it was confirmed that CRNDE promoted angiogenesis by negatively regulating miR-203 expression.
CONCLUSION: lncRNA CRNDE targets the miR-203/VEGFA axis and promotes angiogenesis in HB. These results provide insight into the underlying mechanisms of HB and indicate that CRNDE and miR-203 might be potential targets for HB therapy.
© 2020 S. Karger AG, Basel.

Entities:  

Keywords:  Angiogenesis; CRNDE; Hepatoblastoma; VEGFA; miR-203

Mesh:

Substances:

Year:  2020        PMID: 32182608     DOI: 10.1159/000505131

Source DB:  PubMed          Journal:  Pathobiology        ISSN: 1015-2008            Impact factor:   4.342


  4 in total

1.  Exosomal MicroRNAs as Potential Biomarkers of Hepatic Injury and Kidney Disease in Glycogen Storage Disease Type Ia Patients.

Authors:  Roberta Resaz; Davide Cangelosi; Daniela Segalerba; Martina Morini; Paolo Uva; Maria Carla Bosco; Giuseppe Banderali; Ana Estrella; Corbinian Wanner; David A Weinstein; Annalisa Sechi; Sabrina Paci; Daniela Melis; Maja Di Rocco; Young Mok Lee; Alessandra Eva
Journal:  Int J Mol Sci       Date:  2021-12-28       Impact factor: 5.923

2.  LncRNA MIR205HG accelerates cell proliferation, migration and invasion in hepatoblastoma through the activation of MAPK signaling pathway and PI3K/AKT signaling pathway.

Authors:  Wei Zhang; Feng Liang; Qingfeng Li; Hong Sun; Fei Li; Zhibo Jiao; Jie Lei
Journal:  Biol Direct       Date:  2022-01-07       Impact factor: 4.540

3.  miR-126 in Extracellular Vesicles Derived from Hepatoblastoma Cells Promotes the Tumorigenesis of Hepatoblastoma through Inducing the Differentiation of BMSCs into Cancer Stem Cells.

Authors:  Yu Hu; Hongyan Zai; Wei Jiang; Yuanbing Yao; Zhenglin Ou; Qin Zhu
Journal:  J Immunol Res       Date:  2021-10-29       Impact factor: 4.818

Review 4.  CRNDE: A valuable long noncoding RNA for diagnosis and therapy of solid and hematological malignancies.

Authors:  Xuefei Ma; Wen Jin; Chaoxian Zhao; Xuefeng Wang; Kankan Wang
Journal:  Mol Ther Nucleic Acids       Date:  2022-03-09       Impact factor: 8.886

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.